7.25 USD
↘ 0.15 (2.03%)AT CLOSE (03:59 PM EDT)
Neuraxis, Inc.
NRXSAMEX • USD
7.28
↗ 0.03 (0.34%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
7.28
↗ 0.03 (0.34%)
Market: CLOSED
NRXS is currently priced at $7.25. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 26, 2026.
Open?$7.39
High?$7.51
Low?$7.25
Prev. Close?$7.40
Volume?84.9K
Avg. Volume?180.6K
VWAP?$7.41
Rel. Volume?0.47x
Bid / Ask
Bid?$6.55 × 100
Ask?$8.00 × 100
Spread?$1.45
Midpoint?$7.28
Valuation & Ratios
Market Cap?91.0M
Shares Out?12.6M
Float?8.6M
Float %?68.8%
P/E Ratio?N/A
P/B Ratio?13.52
EPS?-$0.67
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Employees
24
Market Cap
92.9M
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Website
Listed
2023-08-09
Address
11611 N. MERIDIAN ST
CARMEL, IN 46032
Phone: (812) 689-0791
CARMEL, IN 46032
Phone: (812) 689-0791
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?99
Momentum?83
Short Sent.?70
Piotroski F-Score?3/9Weak
Altman Z-Score?5.75Safe
Confidence?48%Low
Short InterestLow
Short % of Float?4.78%Low
Short Interest?412.8K
Days to Cover?2.3
Free Float8.6M
Avg Daily Volume177.1K
Settlement Date2026-10-15
Financial Health
Current Ratio?3.04Strong
Quick Ratio?2.95Strong
Cash Ratio?2.69Strong
Debt/Equity?0.01Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?13.52HIGH▾
Peers100
S&P14
P/S?17.13HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-10.9CHEAP▾
S&P97
EV/Sales?15.57HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-125.5%WEAK▾
S&P3
ROA?-84.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-5633168
Enterprise Value?$82.8M
Fundamentals ratios updated end of day